Russell Investments Group’s Harmony Biosciences HRMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $934K | Sell |
29,556
-2,342
| -7% | -$74K | ﹤0.01% | 2093 |
|
|
2025
Q1 | $1.06M | Sell |
31,898
-14,651
| -31% | -$486K | ﹤0.01% | 2011 |
|
|
2024
Q4 | $1.6M | Sell |
46,549
-5,474
| -11% | -$188K | ﹤0.01% | 1777 |
|
|
2024
Q3 | $2.08M | Buy |
52,023
+44,446
| +587% | +$1.78M | ﹤0.01% | 1675 |
|
|
2024
Q2 | $229K | Sell |
7,577
-26,404
| -78% | -$797K | ﹤0.01% | 2446 |
|
|
2024
Q1 | $1.14M | Buy |
33,981
+5,082
| +18% | +$171K | ﹤0.01% | 1927 |
|
|
2023
Q4 | $933K | Sell |
28,899
-18,209
| -39% | -$588K | ﹤0.01% | 1996 |
|
|
2023
Q3 | $1.54M | Buy |
47,108
+22,114
| +88% | +$725K | ﹤0.01% | 1699 |
|
|
2023
Q2 | $880K | Sell |
24,994
-11,911
| -32% | -$419K | ﹤0.01% | 1996 |
|
|
2023
Q1 | $1.2M | Sell |
36,905
-82,758
| -69% | -$2.7M | ﹤0.01% | 1870 |
|
|
2022
Q4 | $6.59M | Sell |
119,663
-62,671
| -34% | -$3.45M | 0.01% | 959 |
|
|
2022
Q3 | $8.07M | Buy |
182,334
+112,474
| +161% | +$4.98M | 0.02% | 828 |
|
|
2022
Q2 | $3.41M | Buy |
69,860
+57,304
| +456% | +$2.8M | 0.01% | 1295 |
|
|
2022
Q1 | $613K | Buy |
12,556
+4,363
| +53% | +$213K | ﹤0.01% | 2158 |
|
|
2021
Q4 | $348K | Buy |
8,193
+2,321
| +40% | +$98.6K | ﹤0.01% | 2552 |
|
|
2021
Q3 | $224K | Buy |
+5,872
| New | +$224K | ﹤0.01% | 2745 |
|
|
2020
Q4 | – | Sell |
-12,275
| Closed | -$414K | – | 3112 |
|
|
2020
Q3 | $414K | Buy |
+12,275
| New | +$414K | ﹤0.01% | 2479 |
|